drugset / Trial / NCT01836471
A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study was to assess the clinical effect of QAW039 in non-atopic asthmatics taking low dose Inhaled Corticosteroid (ICS) as background therapy.
Timeline
- Start
- 2013-05
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone | Other / unclassified | 100 ug | Inhaled |
| Comparator | Fluticasone | Other / unclassified | 250 ug | Inhaled |
| Subject | fevipiprant | Small molecule | 450 mg | Oral |